Edward Cliff

Edward Cliff from Brigham and Women's Hospital and Natacha Bolaños, Lymphoma Coalition Europe, discuss two major barriers to CAR-T therapy: the high cost and the need to improve access. They explore strategies to reduce costs and ensure global accessibility while prioritizing patient preferences and shared decision making.